References
- Allen J. D., Arnold J. M.O. Comparison of the effects of mexiletine, lignocaine, and procaine amide on canine purkinje fibres. J. Physiol. 1974; 236: 26A
- Allen J. D., Kofiekue J. M., Shanks R. G., Zaidi S. A. The effect of KÖ 1173, a new anti-convulsant agent on experimental cardiac arrhythmias. Brit. J. Pharmacol. 1972; 45: 561
- Batsford W. P., Akhtar M., Caralta A. R., Josephson M. E., Seides S. F., Damato A. N. Effect of atrial stimulation site on the electrophysiological properties of the atrioventricular node in man. Circulation 1974; 50: 283
- Bekheit S., Murtagh J. G., Morton P., Fletcher E. Measurements of sinus impulse conduction from the electrogram of His. Brit. Heart J. 1971; 33: 719
- Cambell N. P.S., Chiaurvedi N. C., Kelly J. C., Strong J. E., Shanks R. G., Pantridge J. F. Mexiletine (KÖ 1173) in the management of ventricular dysrhythmias. Lancet 1973; 2: 404
- Clark R. A., Julian D., Nimmo J., Prescott L. F., Talbot R. Clinical pharmacological studies of KÖ 1173—a new antiarrhythmic agent. Brit. J. Pharmacol. 1973; 47: 622
- Damato A. N., Lau S. H. Clinical value of the electrogram of the conduction system. Progr. cardiovasc. Dis. 1970; 13: 119
- Damato A. N., Lau S. H., Helefant R. H., Stein E., Berkowitz W. O., Cohen S. I. Study of A-V conduction in man using electrode catheter recordings of His bundle activity. Circulation 1969; 39: 287
- Hecht H. H., Kossman C. E., Childers R. W., Langendorf R. J., Lev M., Rosen K. M., Pruitt R. D., Truex R. C., Uhley H. N., Watt T. B. Atrio-ventricular and intra-ventricular conduction. Revised nomenclature and concepts. Amer. J. Cardiol. 1973; 31: 232
- Hoffman B. F., Kao C. Y., Suckling E. E. Refractoriness in cardiac muscle. Ann. J. Physiol. 1957; 190: 473
- Josephson M. E., Caracta A. R., Ricciutti M. A., Lau S. H., Damato A. N. Electrophysiological properties of procaine amide in man. Amer. J. Cardiol. 1974; 33: 596
- Josephson M. E., Seides S. F., Batsford W. P., Weisfogel A. M., Akhtar M., Caracta A. R., Lau S. H., Damato A. N. The electrophysiological effects of intramuscular quinidine on the atrioventricular conducting system in man. Amer. Heart J. 1974; 87: 55
- Kiddie M. A., Kaye CM., Turner P. The influence of urinary pH on the elimination of mexiletine. Brit. J. clin. Pharm. 1974; 1: 229
- Moss A. J., Patton R. D. Anti-arrhythmic Agents. Charles C. Thomas, Springfield 1973
- Narula O. S., Samet P., Janvier R. P. Significance of the sinus node recovery time. Circulation 1972; 45: 140
- Rydén L., Olsson S. B., Kvasnicka J. Electrophysiological effects of the antiarrhythmic quaternary ammonium compound QX-572 in the heart in man with special reference to rat induced changes in effective refractory periods. Cardiovasc. Res. 1975; 9: 81
- Sherlag R. J., Lau S. H., Helfant R. D., Berkowitz W. D., Stein E., Damato A. N. Catheter technique for recording His bundle activity in man. Circulation 1969; 39: 13
- Singh B. N., Vaughan Williams E. M. Investigations of the mode of action of a new antidysrhythmic drug, KÖ 1173. Brit. J. Pharmacol. 1972; 44: 1
- Talbot R. G., Clark R. A., Nimmo J., Neilson J. M.M., Julian D. G., Prescott L. F. Treatment of ventricular arrhythmias with mexiletine (KÖ 1173). Lancet 1973; 2: 399